Last month, however, the FDA issued a 483 inspection report to an Axium unit called Balanced Solutions Compounding Pharmacy for a host of manufacturing violations.
The company at the time didn't respond to The Wall Street Journal's requests for comment about the FDA report on the inspection, released in January 2009.